SANTA BARBARA, Calif. – Affinity Biosensors of Santa Barbara announced Wednesday that the diagnostic company's LifeScale AST system has received clearance from the U.S. Food and Drug Administration. The LifeScale AST system is a benchtop diagnostic platform that provides rapid phenotypic antimicrobial susceptibility tests (AST), for the management of bacteremia in the bloodstream. Bacteria are naturally found in human blood and most won't make you sick, but some bacteria can trigger your body's immune system response and even lead to an infection. Healthcare providers can prescribe antibiotics to treat these infections, but there is a risk of antibiotic-resistant bacteria, so know
Hence then, the article about affinity biosensors of santa barbara receives fda approval of lifescale ast testing device was published today ( ) and is available onNews channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Affinity Biosensors of Santa Barbara receives FDA approval of LifeScale AST testing device )